Phase
Condition
Bulimia
Addictions
Binge Eating Disorder
Treatment
Low UP (meals provided)
Active Control
Low UP (self-guided)
Clinical Study ID
Ages 22-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
22 to 60 years of age
English-speaking
Must own an Android or iPhone Smartphone
Live within a 1-hour radius of the laboratory
endorsement of > 4 symptoms on the YFAS 2.0 completed during eligibility screener;at the time of consent, symptom count must remain above threshold for food addiction (this discrepany is based on a previously found tendency during pilot testing tooverestimate food addiction symptoms at the time of screening)
Willing and able to follow specific dietary instructions provided by the study team
Willing and able to attend 3 in-person lab visits
Willing to complete 4 phone interviews about foods eaten in the past 24 hours
Willing to report daily intake of food
Like the taste of chocolate milkshake (for fMRI scan eligibility only).
Exclusion
Exclusion Criteria:
participants with a self-reported BMI < 18.5 and > 40
Current diagnosis of disorder that may impact study results or the ability to safelycomplete study tasks (hypothyroidism (uncontrolled by medication), diabetes, etc.)
History of food allergies
Unable to respond to brief questionnaires within 90-minutes during the day
Work night shifts or irregular shifts
Restrictive dietary requirements (e.g., vegan) or high levels of picky eating
Medications (e.g., insulin, antipsychotic medications) that may impact study resultsor safe completion of study tasks
Diagnosis of severe mental illness (e.g., schizophrenia, bipolar disorder)
Diagnosis of a restrictive eating disorder (e.g., Anorexia Nervosa, Bulimia Nervosa,purging disorder) within the last 5 years
Current diagnoses of disorders that can impact reward/metabolic functioning
20+ pound weight fluctuation in the last 3-months
Prior weight loss surgery (e.g., bariatric surgery)
Currently pregnant, breastfeeding, trying to get pregnant, or within 6-months ofhaving given birth
High levels or high-risk intake of alcohol or caffeine
Use of tobacco or nicotine in the past month
Use of THC cannabis within the past week
Unwillingness to abstain from THC cannabis, tobacco or nicotine during the mainportion of the study (~22 days)
fMRI contraindications (e.g., claustrophobia, metal implants).
inability to complete a random report within 90 minutes
Study Design
Study Description
Connect with a study center
University of Michigan
Ann Arbor, Michigan 48109
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.